全文获取类型
收费全文 | 2377420篇 |
免费 | 194774篇 |
国内免费 | 4215篇 |
专业分类
耳鼻咽喉 | 34280篇 |
儿科学 | 72805篇 |
妇产科学 | 63010篇 |
基础医学 | 335147篇 |
口腔科学 | 67562篇 |
临床医学 | 215822篇 |
内科学 | 469009篇 |
皮肤病学 | 47954篇 |
神经病学 | 200917篇 |
特种医学 | 96061篇 |
外国民族医学 | 887篇 |
外科学 | 360779篇 |
综合类 | 56262篇 |
现状与发展 | 1篇 |
一般理论 | 978篇 |
预防医学 | 190825篇 |
眼科学 | 55505篇 |
药学 | 177668篇 |
4篇 | |
中国医学 | 4369篇 |
肿瘤学 | 126564篇 |
出版年
2018年 | 24287篇 |
2016年 | 20636篇 |
2015年 | 23338篇 |
2014年 | 33598篇 |
2013年 | 50945篇 |
2012年 | 68903篇 |
2011年 | 72462篇 |
2010年 | 42577篇 |
2009年 | 40952篇 |
2008年 | 68885篇 |
2007年 | 73248篇 |
2006年 | 74118篇 |
2005年 | 72162篇 |
2004年 | 69464篇 |
2003年 | 67127篇 |
2002年 | 66369篇 |
2001年 | 112497篇 |
2000年 | 116567篇 |
1999年 | 98368篇 |
1998年 | 27884篇 |
1997年 | 25542篇 |
1996年 | 25471篇 |
1995年 | 24624篇 |
1994年 | 23180篇 |
1993年 | 21567篇 |
1992年 | 79405篇 |
1991年 | 76409篇 |
1990年 | 73594篇 |
1989年 | 70851篇 |
1988年 | 65860篇 |
1987年 | 64810篇 |
1986年 | 61354篇 |
1985年 | 58407篇 |
1984年 | 44228篇 |
1983年 | 37664篇 |
1982年 | 22894篇 |
1981年 | 20335篇 |
1980年 | 19038篇 |
1979年 | 41303篇 |
1978年 | 28991篇 |
1977年 | 24349篇 |
1976年 | 22833篇 |
1975年 | 23970篇 |
1974年 | 29638篇 |
1973年 | 28047篇 |
1972年 | 26228篇 |
1971年 | 24159篇 |
1970年 | 22755篇 |
1969年 | 21096篇 |
1968年 | 19138篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
Neurological dysfunction of the bladder in workers exposed to dimethylaminopropionitrile 总被引:1,自引:0,他引:1
Neurogenic bladder dysfunction, characterized by hesitancy, need to strain, decreased stream, and increased duration of urination, developed in 104 (63%) of 166 employees working in the manufacture of polyurethane foam. Highest rates of illness (69%) occurred in production workers, and no illness occurred in office or warehouse workers. Onset of the epidemic coincided with introduction of a catalyst, dimethylaminopropionitrile (DMAPN), and monthly case incidence rates increased as DMAPN use increased. Outbreak ceased abruptly when DMAPN use was stopped. Of eight patients who underwent neurourologic testing during recovery, seven lacked either detrusor reflex or normal sensation of bladder filling; seven had a subclinical sensory abnormality; three had prolonged sacral-evoked responses; and two of these three had limb motor neuropathies. Dimethylaminopropionitrile is unique among known neurotoxins in producing urinary symptoms more frequently than limb nerve symptoms. 相似文献
972.
G E Davies A V Thompson Z Niewola G E Burrows E L Teasdale D J Bird D A Phillips 《Occupational and environmental medicine》1983,40(4):442-449
Twenty four volunteers who had been allergic to laboratory animals for some years were examined by means of a questionnaire paying particular attention to symptoms associated with rats and by serological and skin tests with extracts of rat urine (retrospective study). Nasal and eye symptoms were reported by 21 and 16 individuals respectively: 13 had asthma. Positive skin tests and high levels of specific IgE antibody to rat urine extract were found in 17 of the more severely affected individuals and this group included 12 of those with asthma. Latent periods of work with animals before symptoms appeared varied from 0.5 to 12 years. Also 148 individuals were studied during their first year of work with animals (prospective study). Symptoms developing during the year were reported by 15%, asthma by 2%. IgE antibody levels to rat urine were raised in 40% of affected and 6% of the unaffected individuals but there was no significant correlation between symptoms and either antibody levels or positive skin tests. Allergic symptoms developing during the first year of postemployment were, on the whole, much milder than those seen in the retrospective study. A tentative conclusion is that most individuals who become allergic to laboratory animals develop the condition in a mild form during their first year of employment but it appears probable that atopic individuals, although having an equal chance of developing allergy as compared with non-atopic individuals, may eventually progress to a more severe form of the disease. 相似文献
973.
974.
975.
Sally M. Bradberry Sarah A. Cage Alex T. Proudfoot J. Allister Vale 《Adverse drug reactions and toxicological reviews》2005,24(2):93-106
The first pyrethroid pesticide, allethrin, was identified in 1949. Allethrin and other pyrethroids with a basic cyclopropane carboxylic ester structure are type I pyrethroids. The insecticidal activity of these synthetic pyrethroids was enhanced further by the addition of a cyano group to give α-cyano (type II) pyrethroids, such as cypermethrin. The finding of insecticidal activity in a group of phenylacetic 3-phenoxybenzyl esters, which lacked the cyclopropane ring but contained the α-cyano group (and hence were type II pyrethroids) led to the development of fenvalerate and related compounds. All pyrethroids can exist as at least four stereoisomers, each with different biological activities. They are marketed as racemic mixtures or as single isomers. In commercial formulations, the activity of pyrethroids is usually enhanced by the addition of a synergist such as piperonyl butoxide, which inhibits metabolic degradation of the active ingredient. Pyrethroids are used widely as insecticides both in the home and commercially, and in medicine for the topical treatment of scabies and headlice. In tropical countries mosquito nets are commonly soaked in solutions of deltamethrin as part of antimalarial strategies. Pyrethroids are some 2250 times more toxic to insects than mammals because insects have increased sodium channel sensitivity, smaller body size and lower body temperature. In addition, mammals are protected by poor dermal absorption and rapid metabolism to non-toxic metabolites. The mechanisms by which pyrethroids alone are toxic are complex and become more complicated when they are co-formulated with either piperonyl butoxide or an organophosphorus insecticide, or both, as these compounds inhibit pyrethroid metabolism. The main effects of pyrethroids are on sodium and chloride channels. Pyrethroids modify the gating characteristics of voltage-sensitive sodium channels to delay their closure. A protracted sodium influx (referred to as a sodium ‘tail current’) ensues which, if it is sufficiently large and/or long, lowers the action potential threshold and causes repetitive firing; this may be the mechanism causing paraesthesiae. At high pyrethroid concentrations, the sodium tail current may be sufficiently great to prevent further action potential generation and ‘conduction block’ ensues. Only low pyrethroid concentrations are necessary to modify sensory neurone function. Type II pyrethroids also decrease chloride currents through voltage-dependent chloride channels and this action probably contributes the most to the features of poisoning with type II pyrethroids. At relatively high concentrations, pyrethroids can also act on GABA-gated chloride channels, which may be responsible for the seizures seen with severe type II poisoning. Despite their extensive world-wide use, there are relatively few reports of human pyrethroid poisoning. Less than ten deaths have been reported from ingestion or following occupational exposure. Occupationally, the main route of pyrethroid absorption is through the skin. Inhalation is much less important but increases when pyrethroids are used in confined spaces. The main adverse effect of dermal exposure is paraesthesiae, presumably due to hyperactivity of cutaneous sensory nerve fibres. The face is affected most commonly and the paraesthesiae are exacerbated by sensory stimulation such as heat, sunlight, scratching, sweating or the application of water. Pyrethroid ingestion gives rise within minutes to a sore throat, nausea, vomiting and abdominal pain. There may be mouth ulceration, increased secretions and/or dysphagia. Systemic effects occur 4–8 hours after exposure. Dizziness, headache and fatigue are common, and palpitations, chest tightness and blurred vision less frequent. Coma and convulsions are the principal life-threatening features. Most patients recover within 6 days, although there were seven fatalities among 573 cases in one series and one among 48 cases in another. Management is supportive. As paraesthesiae usually resolve in 12–24 hours, specific treatment is not generally required, although topical application of dl-α tocopherol acetate (vitamin E) may reduce their severity. 相似文献
976.
977.
978.
Spontaneous neuronal hyperactivity in the medial and intralaminar thalamic nuclei of patients with deafferentation pain 总被引:6,自引:0,他引:6
Electrical activity was recorded from single cells in the thalamus of 10 patients with chronic pain associated with deafferentation. Under local anesthesia, these patients underwent either electrode implantation or thalamotomy for treatment of their pain. In eight of the 10 patients, single units were identified as discharging spontaneously in high-frequency, often rhythmic, bursts. The discharges were of two types: short bursts comprised of two to six spikes with a burst frequency of one to four per second; and long trains of 30 to 80 spikes of similar frequency. Reconstruction of electrode trajectories indicated that recordings were made from the region corresponding to the lateral aspect of the mediodorsal thalamic nucleus, the central lateral nucleus, a small part of the central median nucleus, and the parafascicular nucleus. In the eight patients in whom spontaneous neuronal burst activity was exhibited, it was impossible to study activity evoked by natural cutaneous stimulation due to the continuous spontaneous neuronal discharges. Both animal and human studies have suggested that pain related to deafferentation is accompanied by spontaneous hyperactivity in the dorsal horn of the spinal cord and in the ventral posterior thalamic nuclei. The authors present evidence of spontaneous neuronal hyperactivity in the intralaminar thalamic nuclei of patients with pain related to deafferentation. The findings suggest that spontaneous neuronal discharge in patients with pain related to deafferentation is more widespread in the central nervous system than has been previously appreciated. The results have important implications for the surgical treatment of chronic pain. 相似文献
979.
980.